Glyburide Not Better Than Subcutaneous Insulin In Gestational Diabetes Perinatal Complications | JAMA

Comparison of the sulfonylurea glyburide and SQ insulin in gestational diabetes: glyburide NOT better than insulin at reducing perinatal complications.

From JAMA: “This noninferiority randomized clinical trial compares the effects of glyburide vs subcutaneous insulin on macrosomia, neonatal hypoglycemia, and hyperbilirubinemia in infants born to women with gestational diabetes.”

Source: Effect of Glyburide vs Subcutaneous Insulin on Perinatal Complications Among Women With Gestational Diabetes: A Randomized Clinical Trial | Neonatology | JAMA | JAMA Network

Advertisements